GlassScriptPhysician profile
Gagan Takhar
NPI 1457914772
$2,749.16
in general payments reported to CMS, 2019-2025
18 companies · $747 in 2025
The $747 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.99 · 2022: $398 · 2023: $914 · 2024: $590 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,250.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,016.57 | 2022-2025 | |
| Leo Pharma INC. | $445.18 | 2022-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $215.32 | 2022-2023 | Taltz, Olumiant |
| Regeneron Healthcare Solutions, INC. | $153.25 | 2021-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $149.45 | 2022-2024 | |
| Pfizer INC. | $124.37 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $98.23 | 2023-2025 | Sotyktu |
| Ucb, INC. | $97.20 | 2022-2025 | Cimzia, Bimzelx |
| Sun Pharmaceutical Industries INC. | $92.51 | 2022-2025 | Ilumya |
| Novartis Pharmaceuticals Corporation | $88.64 | 2022-2025 | |
| Janssen Biotech, INC. | $85.63 | 2023 | Tremfya |
| Organon LLC | $38.98 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $38.63 | 2022-2023 | |
| Dermavant Sciences, INC. | $37.47 | 2022-2023 | Vtama |
| Sandoz INC. | $20.36 | 2023 | Hyrimoz |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $17.62 | 2025 | Sofdra |
| Incyte Corporation | $16.11 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.64 | 2023 | Cyltezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gagan Takhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.